Work

Bioequivalence study of a new oral topotecan formulation, relative to the current topotecan formulation, in patients with advanced solid tumors

Year: 2009

Type: article

Study design: Clinical Trial

Source: International Journal of Clinical Pharmacology and Therapeutics

DOI: 10.5414/cpp47195

Authors: R.L. Oostendorp, J. Loftiss, S. Goel, D.A. Smith, M.M. Dar, P.O. Witteveen, R.B. Cohen, L.D. Lewis, S. Kurian, A. Patnaik, H. Rosing, J.H. Beijnen, E.E. Voest, H. Burris, J.H.M. Schellens

Institutions: The Netherlands Cancer Institute, GlaxoSmithKline (United Kingdom), Utrecht University, Fox Chase Cancer Center, Dartmouth College, West Virginia University, The University of Texas at San Antonio Health Science Center, Slotervaartziekenhuis, Sarah Cannon Research Institute

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2320237417

FWCI: 0.402

Cites:

Cited by: 6

Related to: 10